These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

599 related items for PubMed ID: 31174562

  • 1. Nek2B activates the wnt pathway and promotes triple-negative breast cancer chemothezrapy-resistance by stabilizing β-catenin.
    Shen H, Yan W, Yuan J, Wang Z, Wang C.
    J Exp Clin Cancer Res; 2019 Jun 07; 38(1):243. PubMed ID: 31174562
    [Abstract] [Full Text] [Related]

  • 2. [Expression and significance of Nek2B and β-catenin in triple negative breast cancer].
    Yan WP, Shen HH, Ma WX, Wang ZY, Shang LF, Shen NN, Qi GY, Wei R, Zhang XQ, Wang C.
    Zhonghua Bing Li Xue Za Zhi; 2020 May 08; 49(5):424-429. PubMed ID: 32392924
    [Abstract] [Full Text] [Related]

  • 3. RAC1 GTP-ase signals Wnt-beta-catenin pathway mediated integrin-directed metastasis-associated tumor cell phenotypes in triple negative breast cancers.
    De P, Carlson JH, Jepperson T, Willis S, Leyland-Jones B, Dey N.
    Oncotarget; 2017 Jan 10; 8(2):3072-3103. PubMed ID: 27902969
    [Abstract] [Full Text] [Related]

  • 4. CircRNA_069718 promotes cell proliferation and invasion in triple-negative breast cancer by activating Wnt/β-catenin pathway.
    Zhang J, Xu HD, Xing XJ, Liang ZT, Xia ZH, Zhao Y.
    Eur Rev Med Pharmacol Sci; 2019 Jun 10; 23(12):5315-5322. PubMed ID: 31298383
    [Abstract] [Full Text] [Related]

  • 5. Downregulation of beta-catenin in chemo-tolerant TNBC through changes in receptor and antagonist profiles of the WNT pathway: Clinical and prognostic implications.
    Islam S, Dasgupta H, Basu M, Roy A, Alam N, Roychoudhury S, Panda CK.
    Cell Oncol (Dordr); 2020 Aug 10; 43(4):725-741. PubMed ID: 32430683
    [Abstract] [Full Text] [Related]

  • 6. Upregulation of collagen type X alpha 1 promotes the progress of triple-negative breast cancer via Wnt/β-catenin signaling.
    Peng J, Liu X, Mao Y, Lv M, Ma T, Liu J, Zhou Q, Han Y, Li X, Wang H.
    Mol Carcinog; 2024 Aug 10; 63(8):1588-1598. PubMed ID: 38780151
    [Abstract] [Full Text] [Related]

  • 7. miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer.
    Li HY, Liang JL, Kuo YL, Lee HH, Calkins MJ, Chang HT, Lin FC, Chen YC, Hsu TI, Hsiao M, Ger LP, Lu PJ.
    Breast Cancer Res; 2017 Dec 19; 19(1):133. PubMed ID: 29258605
    [Abstract] [Full Text] [Related]

  • 8. Increase in ADAR1p110 activates the canonical Wnt signaling pathway associated with aggressive phenotype in triple negative breast cancer cells.
    Morales F, Pérez P, Tapia JC, Lobos-González L, Herranz JM, Guevara F, de Santiago PR, Palacios E, Andaur R, Sagredo EA, Marcelain K, Armisén R.
    Gene; 2022 Apr 20; 819():146246. PubMed ID: 35122924
    [Abstract] [Full Text] [Related]

  • 9. Destabilization of β-catenin and RAS by targeting the Wnt/β-catenin pathway as a potential treatment for triple-negative breast cancer.
    Ryu WJ, Lee JD, Park JC, Cha PH, Cho YH, Kim JY, Sohn JH, Paik S, Choi KY.
    Exp Mol Med; 2020 May 20; 52(5):832-842. PubMed ID: 32457491
    [Abstract] [Full Text] [Related]

  • 10. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F, Shang S, Yang YW, Zhang HZ, Xu TL, Yu JJ, Zhou DD, Cui B, Li K, Lv XX, Zhang XW, Liu SS, Yu JM, Wang F, Zhang C, Huang B, Hu ZW.
    Gastroenterology; 2019 Feb 20; 156(3):708-721.e15. PubMed ID: 30365932
    [Abstract] [Full Text] [Related]

  • 11. AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer.
    Chen B, Wang J, Dai D, Zhou Q, Guo X, Tian Z, Huang X, Yang L, Tang H, Xie X.
    J Exp Clin Cancer Res; 2017 May 12; 36(1):65. PubMed ID: 28494797
    [Abstract] [Full Text] [Related]

  • 12. Kinesin family member 23, regulated by FOXM1, promotes triple negative breast cancer progression via activating Wnt/β-catenin pathway.
    Li Z, Yang HY, Zhang XL, Zhang X, Huang YZ, Dai XY, Shi L, Zhou GR, Wei JF, Ding Q.
    J Exp Clin Cancer Res; 2022 May 07; 41(1):168. PubMed ID: 35524313
    [Abstract] [Full Text] [Related]

  • 13. H3K27ac-induced RHOXF2 activates Wnt2/β-catenin pathway by binding to HOXC13 to aggravate the malignant progression of triple negative breast cancer.
    Guo M, Wang R, Nie M, Zhang H, Wang C, Song C, Niu S.
    Cell Signal; 2024 Aug 07; 120():111196. PubMed ID: 38697448
    [Abstract] [Full Text] [Related]

  • 14. Saikosaponin D from Radix Bupleuri suppresses triple-negative breast cancer cell growth by targeting β-catenin signaling.
    Wang J, Qi H, Zhang X, Si W, Xu F, Hou T, Zhou H, Wang A, Li G, Liu Y, Fang Y, Piao HL, Liang X.
    Biomed Pharmacother; 2018 Dec 07; 108():724-733. PubMed ID: 30248540
    [Abstract] [Full Text] [Related]

  • 15. Niclosamide sensitizes triple-negative breast cancer cells to ionizing radiation in association with the inhibition of Wnt/β-catenin signaling.
    Yin L, Gao Y, Zhang X, Wang J, Ding D, Zhang Y, Zhang J, Chen H.
    Oncotarget; 2016 Jul 05; 7(27):42126-42138. PubMed ID: 27363012
    [Abstract] [Full Text] [Related]

  • 16. HePTP promotes migration and invasion in triple-negative breast cancer cells via activation of Wnt/β-catenin signaling.
    Yu L, Wang C, Pan F, Liu Y, Ren X, Zeng H, Shi Y.
    Biomed Pharmacother; 2019 Oct 05; 118():109361. PubMed ID: 31545274
    [Abstract] [Full Text] [Related]

  • 17. KCTD11 inhibits progression of lung cancer by binding to β-catenin to regulate the activity of the Wnt and Hippo pathways.
    Yang M, Han YM, Han Q, Rong XZ, Liu XF, Ln XY.
    J Cell Mol Med; 2021 Oct 05; 25(19):9411-9426. PubMed ID: 34453479
    [Abstract] [Full Text] [Related]

  • 18. Kynurenine 3-monooxygenase upregulates pluripotent genes through β-catenin and promotes triple-negative breast cancer progression.
    Huang TT, Tseng LM, Chen JL, Chu PY, Lee CH, Huang CT, Wang WL, Lau KY, Tseng MF, Chang YY, Chiang TY, Ueng YF, Lee HC, Dai MS, Liu CY.
    EBioMedicine; 2020 Apr 05; 54():102717. PubMed ID: 32268268
    [Abstract] [Full Text] [Related]

  • 19. miR-221/222 activate the Wnt/β-catenin signaling to promote triple-negative breast cancer.
    Liu S, Wang Z, Liu Z, Shi S, Zhang Z, Zhang J, Lin H.
    J Mol Cell Biol; 2018 Aug 01; 10(4):302-315. PubMed ID: 30053090
    [Abstract] [Full Text] [Related]

  • 20. First-in-Class Phosphorylated-p68 Inhibitor RX-5902 Inhibits β-Catenin Signaling and Demonstrates Antitumor Activity in Triple-Negative Breast Cancer.
    Capasso A, Bagby SM, Dailey KL, Currimjee N, Yacob BW, Ionkina A, Frank JG, Kim DJ, George C, Lee YB, Benaim E, Gittleman B, Hartman SJ, Tan AC, Kim J, Pitts TM, Eckhardt SG, Tentler JJ, Diamond JR.
    Mol Cancer Ther; 2019 Nov 01; 18(11):1916-1925. PubMed ID: 31488700
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.